Japanese Medical Equipment Stock News

ISE Chemicals (TSE:4107) has just opened Q1 2026 earnings season with trailing twelve month revenue of ¥39.3b and basic EPS of ¥127.51, underpinned by recent quarterly figures such as Q4 2025 revenue of ¥9,230 million and basic EPS of ¥25.91. Over the last year, revenue has moved from ¥33.3b to ¥39.3b while trailing basic EPS has shifted from ¥99.51 to ¥127.51, alongside net income excluding extra items rising from ¥5,071 million to ¥6,498 million. This sets up a story where higher net profit...

SBI Shinsei Bank (TSE:8303) opened FY 2026 with third quarter revenue of ¥193,823 million and basic EPS of ¥26.49, while trailing 12 month revenue stood at ¥487,269 million and EPS was ¥127.72. Over recent periods, the bank has seen revenue move from ¥392,396 million in the trailing 12 months to Q4 2024 to ¥427,020 million in the trailing 12 months to Q4 2025, with EPS shifting from ¥71.33 to ¥112.70 over the same span, and more recently to ¥127.72 alongside TTM net income of ¥100,734...

TamronLtd (TSE:7740) has just opened Q1 2026 reporting with its recent run of numbers anchored by Q4 2025 revenue of ¥21.0b and basic EPS of ¥10.56, set against a trailing net profit margin of 13.8% compared with 16.4% a year earlier as context. Over recent quarters, revenue has moved from ¥20.0b in Q4 2024 to ¥21.0b in Q4 2025, while quarterly basic EPS shifted from ¥13.94 to ¥10.56, leaving investors weighing solid top line scale against softer profitability. With forecasts pointing to mid...

Itoham Yonekyu Holdings (TSE:2296) has laid out a steady set of FY 2026 numbers, with third quarter revenue of ¥277.7b, basic EPS of ¥114.06 and net income of ¥6,473m anchoring the latest update. The company has seen revenue move from ¥267.6b and basic EPS of ¥105.76 in FY 2025 Q3 to ¥277.7b and ¥114.06 in FY 2026 Q3, while trailing twelve month basic EPS sits at ¥296.33 on revenue of ¥1.1t. This gives a clearer view of how the earnings profile is shaping up over time. With trailing net...

Elan (TSE:6099) heads into Q1 2026 on the back of a steady run of results, with Q4 2025 revenue of ¥14.7b and basic EPS of ¥12.31, capped by trailing twelve month EPS of ¥45.75 alongside earnings growth of 17.5% over the last year. Over recent quarters the company has seen revenue move from ¥12.7b in Q4 2024 to ¥14.7b in Q4 2025, while quarterly EPS shifted from ¥8.64 to ¥12.31, setting up this earnings season around how firmly that roughly 5% net margin can be held or improved. See our full...

Kurashiru (TSE:299A) has entered FY 2026 with Q3 revenue of ¥4.6b and basic EPS of ¥16.32, putting fresh numbers behind its recent run of reported growth forecasts and profitability metrics. Over the past few quarters, revenue has moved from ¥3.0b in FY 2025 Q2 to ¥3.6b in Q4 2025, then to ¥3.8b and ¥4.0b in FY 2026 Q1 and Q2 respectively, while basic EPS progressed from ¥9.54 to ¥9.55, ¥12.58 and ¥13.69 across the same periods, giving investors a steady series of top line and EPS reference...

Earnings and dividend decisions move East Japan Railway into focus East Japan Railway (TSE:9020) is back on investors radar after reporting full year results to March 31, 2026, alongside a board meeting considering a dividend increase from retained earnings. See our latest analysis for East Japan Railway. The earnings announcement and proposed dividend increase have coincided with a sharp shift in sentiment, with the 1-day share price return of 9.21% lifting the share price to ¥3,700. This...

Board meeting puts capital return plans in focus Max (TSE:6454) has called an April 30, 2026 board meeting to review a potential dividend increase, possible changes to its dividend policy, and decisions on acquiring its own shares. These topics go straight to how cash flows back to you as a shareholder. Any outcome from this meeting could influence how investors view Max’s income profile and capital allocation discipline. See our latest analysis for Max. At a share price of ¥1,796, Max has...

GNI Group Ltd. announced that its consolidated subsidiary, Gyre Pharmaceuticals, has enrolled the first patient in a Phase 2/3 trial of its self-developed pirfenidone capsules (Etuary®) for radiation-induced lung injury with or without immune checkpoint inhibitor-related pneumonitis, following Chinese regulatory approval in March 2025. This step advances pirfenidone into oncology supportive care, targeting a serious complication of thoracic cancer treatment where current therapeutic options...

Casio Computer Ltd (TSE:6952) has drawn fresh attention after unveiling the GBX-H5600, the first G-LIDE watch with a heart rate monitor, expanded training metrics, and bio-based resin components aimed at performance and environmental considerations. See our latest analysis for Casio ComputerLtd. Despite the product launch, Casio ComputerLtd’s recent 7 day share price return of a 4.18% decline contrasts with its 30 day share price return of 8.15% and 1 year total shareholder return of 46.16%...

In April 2026, SoftBank Corp. announced it had jointly developed with TOPPAN Holdings a new ultra-light, durable wing skin and testing method for solar High-Altitude Platform Station (HAPS) aircraft, designed to withstand extreme stratospheric UV, ozone and temperature conditions for longer operational periods. This collaboration extends TOPPAN’s advanced multi-layer film and weather-resistance technologies into stratospheric communications infrastructure, opening potential applications in...

In April 2026, Otsuka Holdings Co., Ltd. reported first-quarter 2026 results showing sales of ¥630,342 million and net income of ¥98,348 million, both higher than the same period a year earlier, with basic earnings per share from continuing operations rising to ¥186.31. This combination of higher sales, stronger net income, and improved earnings per share suggests the company converted top-line growth into more efficient profitability in the quarter. We’ll now examine how this stronger...

Kyocera (TSE:6971) has wrapped up FY 2026 with fourth quarter revenue of ¥548.2 billion and basic EPS of ¥32.42, against a current share price of ¥2,746.5, putting hard numbers around a year that saw earnings bounce strongly and margins reset. Over the past six reported quarters, the company has seen quarterly revenue range from ¥478.0 billion to ¥548.2 billion while basic EPS moved from ¥4.09, through a loss equivalent of ¥12.60 per share, to ¥32.42, backed by trailing twelve month EPS of...

Aica Kogyo Company (TSE:4206) drew investor focus after reporting record highs in net sales and profits for the fiscal year, along with another increase in its annual dividend and a higher payout forecast. See our latest analysis for Aica Kogyo Company. The record earnings, higher dividend and upbeat outlook come after a mixed year in the market, with a modest 1-year total shareholder return of 4.06% alongside a 3-year total shareholder return of 29.70%, hinting at momentum that has cooled...

Mitsubishi Corporation has released its full-year results for the period ended March 31, 2026, reporting sales of ¥18.92 trillion and net income of ¥800.46 billion, both slightly higher sales but lower profit than the previous year. The earnings report also showed a reduction in basic earnings per share from continuing operations to ¥210.92, highlighting pressure on profitability despite revenue growth. We’ll now examine how this weaker earnings profile, alongside the planned sale of...

Dividend decision puts SKY Perfect JSAT in focus SKY Perfect JSAT (TSE:9412) has called a board meeting for 28 April 2026 to consider dividends from retained earnings for the fiscal year ended 31 March 2026, a key point for income focused investors. See our latest analysis for SKY Perfect JSAT. Investor attention around the dividend decision comes after a strong run in the shares, with a 30 day share price return of 16.58% and a year to date gain of 73.24%, while the 1 year total shareholder...

Board meeting puts Tobu Railway’s dividend policy in focus Tobu Railway (TSE:9001) has called an April 30, 2026 board meeting to consider revising its year end dividend forecast, a move that puts shareholder payouts and capital allocation firmly on investors’ radar. See our latest analysis for Tobu Railway. The share price has risen in the short term, with a 1 day share price return of 2.31% and a 7 day share price return of 2.97%. The 1 year total shareholder return of 9.43% contrasts with a...

Takara StandardLtd (TSE:7981) has wrapped up FY 2026 with fourth quarter revenue of ¥60.1 billion and Basic EPS of ¥37.38, while trailing twelve month revenue stood at ¥252.8 billion and EPS at ¥231.88, alongside earnings growth of 35.9% over the last year. Over recent periods, revenue has ranged from ¥59.1 billion to ¥69.5 billion per quarter, with quarterly EPS moving between ¥30.28 and ¥89.68, giving investors a clear view of how the top line and per share earnings have tracked into the...

ITOCHU-SHOKUHIN (TSE:2692) has wrapped up FY 2026 with fourth quarter revenue of ¥161.9b and a basic EPS loss of ¥46.35, against a trailing twelve month EPS of ¥652.09 on revenue of ¥720.2b that came with 0.8% earnings growth and a 1.1% net margin over the period. Over recent quarters, revenue has ranged from ¥175.1b in Q1 2026 to ¥192.5b in Q3 2026, while quarterly EPS has moved between ¥196.10 and ¥292.35 before the latest quarterly loss. This leaves investors to weigh a solid full year...

NS United Kaiun Kaisha (TSE:9110) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥58,520 million and basic EPS of ¥252.15, rounding out a year in which trailing twelve month EPS reached ¥1,022.47 on revenue of ¥229,784 million and earnings growth of 29.4%. Over the last year, the company has seen net profit margin move from 7.5% to 10.5%, while trailing twelve month net income excluding extra items reached ¥24,095 million, supported by a ¥7.0b one off gain that is front...

Latest FY 2026 Results Set the Stage for Meiwa's Next Chapter Meiwa (TSE:8103) closed FY 2026 with fourth quarter revenue of ¥43.1b and basic EPS of ¥29.85, rounding out a year where trailing twelve month revenue reached ¥164.9b and EPS came in at ¥83.98. Over recent periods, revenue has moved from ¥156.7b on a trailing basis in FY 2025 to ¥164.9b in FY 2026, while trailing EPS has shifted from ¥83.27 to ¥83.98. This gives investors a clear view of how top line and per share profitability...

M3, Inc. held a board meeting on May 1, 2026, alongside releasing fiscal 2026 results that showed double-digit revenue and profit growth, a higher annual dividend, and new plans for share repurchases under its Articles of Incorporation. The company also issued an upbeat forecast for fiscal 2027, projecting revenue of ¥400.0 billion and profit attributable to owners of the parent of ¥53.0 billion, underscoring management’s confidence in its healthcare-related digital services model. Next, we...

Why COSMOS Pharmaceutical’s latest update matters for shareholders COSMOS Pharmaceutical (TSE:3349) reported 7.7% sales growth with modest profit gains for the nine months to February 2026, maintained its full year forecast, and flagged an annual dividend increase to ¥75. See our latest analysis for COSMOS Pharmaceutical. The latest earnings and dividend news comes after a weaker period for the share price, with a 30 day share price return of 8.34% and a year to date share price return...

Okura Industrial Q1 2026 earnings snapshot Okura Industrial (TSE:4221) opened its Q1 2026 scorecard with revenue of ¥24.0b and basic EPS of ¥130.49, setting the tone for how the year is starting at a share price of ¥4,910. Over recent quarters the company has seen revenue move from ¥21.7b in Q1 2025 to ¥22.4b in Q4 2025 and now ¥24.0b, while basic EPS has ranged from ¥108.47 to ¥130.49 over the same span. This gives a clear sense of how the top and bottom line are tracking into this latest...